SLC1A5 and non-small cell lung carcinoma: In a subpopulation of NSCLC cell lines overexpressing SLC1A5, inactivating SLC1A5 either genetically or pharmacologically could reduce Gln consumption, inhibit cell growth, and induce its autophagy and apoptosis.